Neeli P - Search Results

1

Therapeutic cancer vaccines: From biological mechanisms and engineering to ongoing clinical trials.

Sobhani N, Scaggiante B, Morris R, Chai D, Catalano M, Tardiel-Cyril DR, Neeli P, Roviello G, Mondani G, Li Y. Sobhani N, et al. Among authors: neeli p. Cancer Treat Rev. 2022 Sep;109:102429. doi: 10.1016/j.ctrv.2022.102429. Epub 2022 Jun 22. Cancer Treat Rev. 2022. PMID: 35759856 Free PMC article. Review.

2

AR-V7 in Metastatic Prostate Cancer: A Strategy beyond Redemption.

Sobhani N, Neeli PK, D'Angelo A, Pittacolo M, Sirico M, Galli IC, Roviello G, Nesi G. Sobhani N, et al. Int J Mol Sci. 2021 May 24;22(11):5515. doi: 10.3390/ijms22115515. Int J Mol Sci. 2021. PMID: 34073713 Free PMC article. Review.

3

p53 Antibodies as a Diagnostic Marker for Cancer: A Meta-Analysis.

Sobhani N, Roviello G, D'Angelo A, Roudi R, Neeli PK, Generali D. Sobhani N, et al. Molecules. 2021 Oct 14;26(20):6215. doi: 10.3390/molecules26206215. Molecules. 2021. PMID: 34684792 Free PMC article.

4

The co-delivery of adenovirus-based immune checkpoint vaccine elicits a potent anti-tumor effect in renal carcinoma.

Jiang N, Zheng Y, Ding J, Wang J, Zhu F, Wang M, Sobhani N, Neeli P, Wang G, Li H, Zheng J, Chai D. Jiang N, et al. Among authors: neeli p. NPJ Vaccines. 2023 Aug 4;8(1):109. doi: 10.1038/s41541-023-00706-x. NPJ Vaccines. 2023. PMID: 37542081 Free PMC article.

5

Expanding anti-CD38 immunotherapy for lymphoid malignancies.

Wang X, Yu X, Li W, Neeli P, Liu M, Li L, Zhang M, Fang X, Young KH, Li Y. Wang X, et al. Among authors: neeli p. J Exp Clin Cancer Res. 2022 Jun 28;41(1):210. doi: 10.1186/s13046-022-02421-2. J Exp Clin Cancer Res. 2022. PMID: 35765110 Free PMC article.

6

Doxorubicin induces prostate cancer drug resistance by upregulation of ABCG4 through GSH depletion and CREB activation: Relevance of statins in chemosensitization.

Mallappa S, Neeli PK, Karnewar S, Kotamraju S. Mallappa S, et al. Mol Carcinog. 2019 Jul;58(7):1118-1133. doi: 10.1002/mc.22996. Epub 2019 Mar 4. Mol Carcinog. 2019. PMID: 30834613

7

AMPK inhibits MTDH expression via GSK3β and SIRT1 activation: potential role in triple negative breast cancer cell proliferation.

Gollavilli PN, Kanugula AK, Koyyada R, Karnewar S, Neeli PK, Kotamraju S. Gollavilli PN, et al. FEBS J. 2015 Oct;282(20):3971-85. doi: 10.1111/febs.13391. Epub 2015 Aug 20. FEBS J. 2015. PMID: 26236947 Free article.

8

Metformin regulates mitochondrial biogenesis and senescence through AMPK mediated H3K79 methylation: Relevance in age-associated vascular dysfunction.

Karnewar S, Neeli PK, Panuganti D, Kotagiri S, Mallappa S, Jain N, Jerald MK, Kotamraju S. Karnewar S, et al. Biochim Biophys Acta Mol Basis Dis. 2018 Apr;1864(4 Pt A):1115-1128. doi: 10.1016/j.bbadis.2018.01.018. Epub 2018 Jan 31. Biochim Biophys Acta Mol Basis Dis. 2018. PMID: 29366775 Free article.

9

A novel metadherinΔ7 splice variant enhances triple negative breast cancer aggressiveness by modulating mitochondrial function via NFĸB-SIRT3 axis.

Neeli PK, Gollavilli PN, Mallappa S, Hari SG, Kotamraju S. Neeli PK, et al. Oncogene. 2020 Mar;39(10):2088-2102. doi: 10.1038/s41388-019-1126-6. Epub 2019 Dec 5. Oncogene. 2020. PMID: 31806873

10

sp³ -Rich Glycyrrhetinic Acid Analogues Using Late-Stage Functionalization as Potential Breast Tumor Regressing Agents.

Kallepu S, Neeli PK, Mallappa S, Nagendla NK, Reddy Mudiam MK, Mainkar PS, Kotamraju S, Chandrasekhar S. Kallepu S, et al. ChemMedChem. 2020 Oct 5;15(19):1826-1833. doi: 10.1002/cmdc.202000400. Epub 2020 Sep 7. ChemMedChem. 2020. PMID: 32893968

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

19 results

Search Page